Charles Russell Speechlys advises Kreos Capital V Limited on its additional growth capital investment of up to €20 million in Kiadis Pharma NV.
Charles Russell Speechlys has advised Kreos Capital V (UK) Limited on its additional growth capital investment of up to €20 million in Kiadis Pharma NV (“Kiadis Pharma”), a Dutch company listed on Euronext Amsterdam and Euronext Brussels. This is a follow on investment by Kreos subsequent to its €15 million growth capital investment in Kiadis Pharma which completed in 2017.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer and more effective for patients suffering from blood cancers and inherited blood disorders. Kiadis Pharma is focused on two therapeutic indications: leukemia (a common form of blood cancer) with its lead product ATIR101 and thalassemia (an inherited blood disorder) with its ATIR201 product.
Kiadis Pharma announced to the market that it will use the financing to advance the Phase 3 clinical development of ATIR101, to prepare for a possible commercial launch in Europe and for general corporate purposes.
The Charles Russell Speechlys core team comprised Chris Putt (Partner), Rossana Conti (Legal Director), Amelly Kok (Associate) and Alice Mason (Corporate Trainee) from our Corporate Team. Foreign counsels whom have advised on this transaction are Fruytier Lawyers in Business (Dutch law), Borden Ladner Gervais LLP (Canadian law), Avocado Rechtsanwälte (German law) and Golenbock Eiseman Assor Bell & Peskoe LLP (US law).
Our thinking
Sarah Rowley
Charity Training series: Session 2
Join us for the second session in our Charity Training series where we will cover training for Charity Trustees and Senior Executives.
Sarah Rowley
Charity Training series: Session 1
Join us for the first session in our Charity Training series where we will discuss ESG for Charities.
Charlotte Posnansky
VV v VV - Just 5 months of marriage and the most expensive train ticket ever?
Mark Howard
Charles Russell Speechlys advises Content+Cloud on the acquisition of award-winning service provider Azzure IT
Content+Cloud continues its growth journey, this is our 7th successful transaction for them.
Dominic Lawrance
Dominic Lawrance talks to Spear's Magazine about UK cryptocurrency tax
What HNWs should know about UK cryptocurrency tax
Sarah Keens
Being Green - The Struggle for Power
Everything you need to know about Green Leases
Rose Carey
Is the UK open for business? A discussion with the Home Office
We hosted an immigration webinar with the policymakers from the Home Office.
Louise Ward
Louise Ward writes for EG on what UK investors can gain from an overseas life sciences partner
What UK investors can gain from an overseas life sciences partner
Sonia Kenawy
Sonia Kenawy writes for New Law Journal on cryptocurrency and security for costs
Sonia Kenawy writes for New Law Journal on cryptocurrency and security for costs
David Haines
New Arbitration Scheme for Commercial Arrears goes live
Everything you need to know about the new Arbitration Scheme for Commercial Arrears
Charlotte Healy
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Pei Li Kew
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Charlotte Duly
Charlotte Duly writes for CITMA Review on the China Tang trade mark infringement case
Charlotte Duly writes for CITMA Review on the China Tang trade mark infringement case
Mark Howard
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Oliver Park
Building Safety Act 2022
Everything you need to know about the Building Safety Act 2022
Jonathan McDonald
Jonathan McDonald provides comment for City AM on the Data Reform Bill announced in the Queen's Speech
Jonathan McDonald provides comment for City AM on the Data Reform Bill announced in the Queen's Speech
Claire Fallows
CoStar quotes Claire Fallows on the new infrastructure levy announced in the Queen's Speech
CoStar quotes Claire Fallows on the new infrastructure levy announced in the Queen's Speech
Charlotte Posnansky
Depp v Heard - will transparency in the English family court increase public confidence or feed the insatiably prurient public appetite?
Nick White
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million.
Hope Wilson
Hope Wilson writes for the EG Legal Q&A on qualifying criteria
Hope Wilson writes for the EG Legal Q&A on qualifying criteria